ObjectiveTo overview the various molecular biological index to judge the prognosis of intrahepatic cholangiocarcinoma (ICC), in order to promote ICC patients follow-up treatment, improve survival rate, and quality of life of the patients. Methods"ICC" and "prognostic factor" were searched as key words by PubMed and CNKI series full-text database retrieval systems from 2000 to 2015. Totally 48 English papers and 15 Chinese papers were obtained. Choice criteria:the molecular biological index that affect the prognosis of ICC patients, and can effectively guide treatment. According to the choice criteria, 45 papers were finally analyzed. ResultsThe indicators of Homer1, mucin 1 (MUC1)\mucin 4 (MUC4), lactate dehydrogenase A (LDH-A), Beclin1, Smad4, protein tyrosine kinase-7 (PTK7), IMP3, cytokeratin 7 (CK7)/cytokeratin 20 (CK20), and sphingosine kinase 1 (SPHK1) could be used as prognostic factors in the survival of patients with ICC, and to determine tumor size and stage, vascular invasion, nerve injury, and lymph node metastasis, are of great clinical significance. ConclusionThese indicators have a significant meanning in the prognosis of ICC and the adjustment of the follow-up treatment.
ObjectiveTo investigate the risk factors for retinopathy in type 2 diabetes patients. MethodsA total of 112 patients with type 2 diabetes treated between December 2009 and December 2012 were divided into two groups. Fifty-two patients had no diabetic retinopathy (NDR group) and 60 had diabetic retinopathy (DR group). Blood pressure, blood lipids, and blood glucose were detected to analyze the correlation of retinopathy with disease course, blood pressure, blood lipid, and blood sugar. ResultsDisease course was longer and blood glucose level was higher in DR group than in NDR group (P<0.05). Logistic regression analysis results showed that the incidence of retinopathy was correlated with blood glucose[OR=1.490, 95% CI (1.123, 1.976), P=0.006] and disease course[OR=2.207, 95% CI (1.579, 3.085), P=0.000]. ConclusionBlood glucose and disease course may be the risk factors for DR. Active control of the blood glucose can be benefit for the prevention and treatment of DR.